Quest Diagnostics to Develop MCaST Blood Test
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read MorePosted by Chris Wolski | Jun 11, 2025 | Cancer |
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read MorePosted by Chris Wolski | Jun 11, 2025 | Cancer |
Florida Cancer Specialists & Research Institute now offers liquid biopsy, a minimally invasive blood test that enhances cancer diagnosis.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Cancer |
Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.
Read MorePosted by Chris Wolski | Jun 2, 2025 | Immunoassay |
Vizgen and Hamamatsu Photonics have partnered to integrate advanced multiplex imaging and assay technologies, streamlining workflows.
Read MorePosted by Chris Wolski | May 30, 2025 | Cancer |
Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.
Read More